Polar Asset Management Partners’s Ibere Pharmaceuticals IBER Stock Holding History

Polar Asset Management Partners’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-678,918	Closed	-$6.85M	–	1297
2022 Q4	$6.85M	Hold	678,918	–	–	0.08%	332
2022 Q3	$6.73M	Hold	678,918	–	–	0.08%	381
2022 Q2	$6.66M	Buy	678,918 +178,918	+36%	+$1.75M	0.08%	381
2022 Q1	$4.91M	Hold	500,000	–	–	0.05%	441
2021 Q4	$4.86M	Hold	500,000	–	–	0.05%	428
2021 Q3	$4.84M	Hold	500,000	–	–	0.05%	419
2021 Q2	$4.83M	Buy	+500,000	New	+$4.87M	0.05%	404

Polar Asset Management Partners's IBER Position: Q1 2023 in Review

Polar Asset Management Partners sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 678,918 shares — an estimated $6.85M sold.

Polar Asset Management Partners first reported a position in IBER in Q2 2021 and held it in 7 quarters. The position peaked at $6.85M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Polar Asset Management Partners reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Polar Asset Management Partners sold 678,918 Ibere Pharmaceuticals shares in Q1 2023, an estimated $6.85M.
Polar Asset Management Partners first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Polar Asset Management Partners's Ibere Pharmaceuticals position peaked at $6.85M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.